We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current NUVB market cap is 711.9M. The company's latest EPS is USD -0.3461 and P/E is -9.30.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.34M | -24.34M | -26.52M | -26.13M | -26.34M |
| Net Income | -27.2M | -20.85M | -21.73M | -20.64M | -19.65M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -3.06M | -93.32M | -119.73M | -99.82M |
| Net Income | -3.05M | -86.85M | -104.2M | -75.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 686.49M | 672.14M | 657.06M | 641.41M | 630.87M |
| Total Liabilities | 18.55M | 17.07M | 15.99M | 16.78M | 19.28M |
| Total Equity | 667.94M | 655.08M | 641.07M | 624.63M | 611.59M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 145M | 776.15M | 672.14M | 621.48M |
| Total Liabilities | 2.8M | 30.15M | 17.07M | 16.36M |
| Total Equity | 5M | 746M | 655.08M | 605.12M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -79.94M | -96.11M | -19.33M | -36.82M | -52.97M |
| Investing | 85.29M | 63.46M | -52M | -14.65M | -24.24M |
| Financing | 920k | 1.33M | 298k | 431k | 508k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -701k | -68.19M | -96.11M | -68M |
| Investing | -143.75M | -454.67M | 63.46M | 8.92M |
| Financing | 145.36M | 625.53M | 1.33M | 628k |
| Market Cap | 711.9M |
| Price to Earnings Ratio | -9.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 16.54 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 219.05M |
| Average Volume (1 week) | 1.48M |
| Average Volume (1 Month) | 1.24M |
| 52 Week Change | 101.86% |
| 52 Week High | 4.1598 |
| 52 Week Low | 0.95 |
| Spread (Intraday) | 0.27 (8.26%) |
| Company Name | Panacea Acquisition Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ecor1cap.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
